We have previously shown that blocking NFκB in HEp2 tumor cells decreased IL-6 and IL-8 secretion substantially and resulted in an increased sensitivity of HEp2 tumor cells to NK cell mediated cytotoxicity [19], [20]. Here, NFKB1 is linked to neoplasm.